Mechanisms of mutant p53 stabilization in cancer

Sub-Cellular Biochemistry

Volumn 85, Issue , 2014, Pages 187-197

  Frum, Rebecca A ^a   Grossman, Steven R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

ATM; DNA damage; Gain of function; Mdm2; p53; Proteasome; Stability; Ubiquitin

Indexed keywords

MDM2 PROTEIN, HUMAN; PROTEIN MDM2; PROTEIN P53; TP53 PROTEIN, HUMAN;

GENETICS; HUMAN; METABOLISM; MUTATION; NEOPLASM; TUMOR SUPPRESSOR GENE;

GENES, P53; HUMANS; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84922391461     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-9211-0_10     Document Type: Article

References (37)

1. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis-the p53 network. J Cell Sci 116(Pt 20): 4077-4085.
2. Lane D (2004) Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy. Carcinogenesis 25(7): 1077-1081.
3. Oren M, Rotter V (2010) Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2(2): a001107.
4. Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA et al (2008) The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 22(10): 1337-1344.
5. Moll UM, Petrenko O (2003) The MDM2-p53 interaction. Mol Cancer Res 1(14): 1001-1008.
6. Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6(12): 909-923.
7. Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Grossman SR (2009) CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci U S A 106(38): 16275-16280.
8. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX et al (1998) p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 2(4): 405-415.
9. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O et al (2001) ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage. Genes Dev 15(9): 1067-1077.
10. Cheng Q, Chen L, Li Z, Lane WS, Chen J (2009) ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J 28(24): 3857-3867.
11. Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D (1999) Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A 96(26): 14973-14977.
12. Appella E, Anderson CW (2001) Post-translational modiflcations and activation of p53 by genotoxic stresses. Eur J Biochem 268(10): 2764-2772.
13. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L et al (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281(5383): 1674-1677.
14. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K et al (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281(5383): 1677-1679.
15. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY et al (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13(2): 152-157.
16. Stolz A, Ertych N, Bastians H (2011) Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin Cancer Res 17(3): 401-405.
17. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD (1999) Phosphorylation of ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci U S A 96(24): 13777-13782.
18. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M et al (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18(21): 3205-3212.
19. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A 89(16): 7491-7495.
20. Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15(10): 1179-1189.
21. Suh YA, Post SM, Elizondo-Fraire AC, Maccio DR, Jackson JG, El-Naggar AK et al (2011) Multiple stress signals activate mutant p53 in vivo. Cancer Res 71(23): 7168-7175.
22. Chao C, Saito S, Anderson CW, Appella E, Xu Y (2000) Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci U S A 97(22): 11936-11941.
23. Li D, Marchenko ND, Schulz R, Fischer V, Velasco-Hernandez T, Talos F et al (2011) Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res 9(5): 577-588.
24. Al-Hakim A, Escribano-Diaz C, Landry MC, O'Donnell L, Panier S, Szilard RK et al (2010) The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair (Amst) 9(12): 1229-1240.
25. Myung J, Kim KB, Crews CM (2001) The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 21(4): 245-273.
26. Lee JT, Gu W (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17(1): 86-92.
27. Esser C, Scheffner M, Hohfeld J (2005) The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem 280(29): 27443-27448.
28. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S et al (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112(6): 779-791.
29. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P et al (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429(6987): 86-92.
30. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W (2005) ARF-BP1/mule is a critical mediator of the ARF tumor suppressor. Cell 121(7): 1071-1083.
31. Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, Degenhardt YY et al (2006) Critical role for daxx in regulating Mdm2. Nat Cell Biol 8(8): 855-862.
32. Yamasaki S, Yagishita N, Sasaki T, Nakazawa M, Kato Y, Yamadera T et al (2007) Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'synoviolin'. EMBO J 26(1): 113-122.
33. Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J et al (2004) Topors functions as an E3 ubiquitin ligase with speciflc E2 enzymes and ubiquitinates p53. J Biol Chem 279(35): 36440-36444.
34. Love IM, Grossman SR (2012) It takes 15 to tango: making sense of the many ubiquitin ligases of p53. Genes Cancer 3(3-4): 249-263.
35. Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL (2006) Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 23(2): 251-263.
36. Lukashchuk N, Vousden KH (2007) Ubiquitination and degradation of mutant p53. Mol Cell Biol 27(23): 8284-8295.
37. Wiech M, Olszewski MB, Tracz-Gaszewska Z, Wawrzynow B, Zylicz M, Zylicz A (2012) Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2. PLoS One 7(12): e51426.